NovaBay Pharmaceuticals, Inc. Non-operating Interest Expenses

Non-operating Interest Expenses of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Non-operating Interest Expenses growth rates and interactive chart. Interest expense that is usually non-recurring and not tied to a company's operations. It is stated separately on the income statement to differentiate it from interest expenses.


Highlights and Quick Summary

  • Non-operating Interest Expenses for the quarter ending December 31, 2020 was $15 Thousand
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Non-operating Interest Expenses of NovaBay Pharmaceuticals, Inc.

Most recent Non-operating Interest Expensesof NBY including historical data for past 10 years.

Interactive Chart of Non-operating Interest Expenses of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Non-operating Interest Expenses for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $0.02

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology